0001375151-19-000131.txt : 20191127
0001375151-19-000131.hdr.sgml : 20191127
20191127161425
ACCESSION NUMBER: 0001375151-19-000131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191125
FILED AS OF DATE: 20191127
DATE AS OF CHANGE: 20191127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FARR STEPHEN J
CENTRAL INDEX KEY: 0001247666
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 191258020
MAIL ADDRESS:
STREET 1: SFARR@ZOGENIX.COM
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 500
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 500
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_157488924668533.xml
FORM 4
X0306
4
2019-11-25
0
0001375151
ZOGENIX, INC.
ZGNX
0001247666
FARR STEPHEN J
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
1
1
0
0
President and CEO
Common Stock
2019-11-25
4
M
0
34225
10.35
A
90752
D
Common Stock
2019-11-25
4
S
0
34225
50
D
56527
D
Stock Option (Right to Buy)
10.35
2019-11-25
4
M
0
34225
0
D
2026-03-13
Common Stock
34225.0
129987
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The option was granted on March 14, 2016 and vests in a series of forty-eight (48) successive, equal monthly installments beginning on April 14, 2016, subject to the reporting person's continuous service to the Company on each vesting date.
/s/ Thomas Doyle, Attorney-in-fact for Stephen Farr
2019-11-27